Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electrosurgery: VaporTrode

D M Weiner1, S A Kaplan

  • 1Department of Urology, Columbia University, New York, NY 10032, USA.

European Urology
|February 6, 1999
PubMed
Summary
This summary is machine-generated.

Transurethral electrovaporization of the prostate offers a promising alternative to traditional transurethral resection of the prostate (TURP), potentially reducing patient morbidity and healthcare costs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Cell communication and signaling : CCS·2021
Same author

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER.

International journal of clinical practice·2014
Same author

Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.

Drugs & aging·2014
Same author

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH.

Current bladder dysfunction reports·2013
Same author

Systematic review of the relationship between bladder and bowel function: implications for patient management.

International journal of clinical practice·2013
Same author

A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.

International journal of clinical practice·2012
Same journal

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

European urology·2026
Same journal

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

European urology·2026
Same journal

In Memory of Paul Mitrofanoff (1934-2025).

European urology·2026
Same journal

Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

European urology·2026
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
Same journal

Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.

European urology·2026
See all related articles

Area of Science:

  • Urology
  • Minimally Invasive Surgery

Background:

  • Standard transurethral resection of the prostate (TURP) has high success rates but is associated with significant patient morbidity.
  • There is a need for alternative techniques to reduce morbidity and healthcare costs associated with BPH treatment.

Purpose of the Study:

  • To evaluate transurethral electrovaporization of the prostate as a potentially safer and more cost-effective alternative to TURP.
  • To assess the efficacy and morbidity profile of transurethral electrovaporization using the VaporTrode instrument.

Main Methods:

  • Transurethral electrovaporization utilizes modified transurethral technology with an increased electrode surface area and high electrical energy delivery.
  • The VaporTrode instrument, a key component, facilitates vaporization, desiccation, and coagulation of prostate tissue.

Related Experiment Videos

  • Evaluation is based on published reports examining TURP-like efficacy and morbidity outcomes.

    • Main Results:

    • Transurethral electrovaporization shows encouraging early results, demonstrating TURP-like efficacy.
    • This technique appears to significantly minimize patient morbidity compared to standard TURP.
    • The VaporTrode instrument is extensively studied and widely applied due to promising outcomes.

    Conclusions:

    • Transurethral electrovaporization of the prostate is a viable alternative to TURP, offering comparable efficacy with reduced morbidity.
    • The technique's low cost and favorable safety profile contribute to its increasing popularity and application in treating benign prostatic hyperplasia (BPH).